Results
3051
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
3051 companies
Hoechst Pakistan
Market Cap: PK₨36.7b
Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨3,809.82
7D
-0.6%
1Y
81.4%
argenx
Market Cap: €37.0b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€604.00
7D
6.8%
1Y
29.0%
Eli Lilly
Market Cap: US$657.1b
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.
LLY
US$732.58
7D
2.9%
1Y
-23.7%
Takara Bio
Market Cap: JP¥109.6b
Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.
4974
JP¥910.00
7D
-6.7%
1Y
-12.6%
Henan Lingrui Pharmaceutical
Market Cap: CN¥13.2b
Produces and sells medicines in China.
600285
CN¥23.43
7D
-2.9%
1Y
0.3%
BDH Industries
Market Cap: ₹1.9b
Engages in the manufacture and sale of therapeutic formulations covering a range of pharmaceuticals in India and Internationally.
524828
₹327.30
7D
12.4%
1Y
-7.2%
Livzon Pharmaceutical Group
Market Cap: CN¥33.6b
Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People’s Republic of China.
000513
CN¥40.40
7D
-1.5%
1Y
12.3%
Orion Oyj
Market Cap: €9.6b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€68.20
7D
-1.7%
1Y
42.2%
Hikma Pharmaceuticals
Market Cap: UK£4.0b
Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.
HIK
UK£17.85
7D
-2.8%
1Y
-10.0%
CorMedix
Market Cap: US$1.1b
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$14.83
7D
8.3%
1Y
137.7%
Merck KGaA
Market Cap: €47.1b
Operates as a science and technology company in Germany.
MRK
€108.30
7D
-3.4%
1Y
-38.4%
Catalyst Pharmaceuticals
Market Cap: US$2.5b
A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
CPRX
US$20.59
7D
-2.3%
1Y
1.7%
Camurus
Market Cap: SEK 42.8b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 720.00
7D
3.2%
1Y
0.8%
Duopharma Biotech Berhad
Market Cap: RM 1.3b
An investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally.
DPHARMA
RM 1.37
7D
3.0%
1Y
13.2%
Gilead Sciences
Market Cap: US$139.7b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$112.97
7D
-1.6%
1Y
43.0%
KPC PharmaceuticalsInc
Market Cap: CN¥10.8b
A pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People’s Republic of China and internationally.
600422
CN¥14.32
7D
-0.5%
1Y
-0.3%
Kalbe Farma
Market Cap: Rp57.6t
Develops, manufactures, and trades in pharmaceutical products in Indonesia.
KLBF
Rp1,215.00
7D
-10.3%
1Y
-26.4%
Tianjin Ringpu Bio-TechnologyLtd
Market Cap: CN¥10.2b
Engages in the research and development, production, and sale of veterinary raw materials, drug preparation, functional additives, and veterinary biological products.
300119
CN¥22.42
7D
-3.7%
1Y
85.4%
Changzhou Qianhong BiopharmaLTD
Market Cap: CN¥12.9b
Manufactures and distributes polysaccharide and protease drugs in China.
002550
CN¥10.35
7D
-5.0%
1Y
98.7%
ADMA Biologics
Market Cap: US$4.1b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$17.26
7D
-3.0%
1Y
-0.3%
ACADIA Pharmaceuticals
Market Cap: US$4.4b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
ACAD
US$25.99
7D
1.0%
1Y
56.8%
Pharma Mar
Market Cap: €1.4b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.
PHM
€81.30
7D
-1.4%
1Y
99.3%
Novartis
Market Cap: CHF 195.8b
Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 101.16
7D
-0.8%
1Y
-0.9%
Kahira Pharmaceuticals & Chemical Industries
Market Cap: ج.م3.2b
Engages in the manufacturing and sale of pharmaceuticals, medical preparations, cosmetics, and materials in Egypt.
CPCI
ج.م215.97
7D
2.6%
1Y
195.8%
Granules India
Market Cap: ₹119.4b
Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally.
532482
₹491.95
7D
7.4%
1Y
-31.4%
Dong-A Socio Holdings
Market Cap: ₩715.7b
Engages in the pharmaceutical business in South Korea.
A000640
₩111,200.00
7D
4.8%
1Y
-8.9%
Square Pharmaceuticals
Market Cap: ৳197.3b
Manufactures, markets, and sells pharmaceutical products in Bangladesh and internationally.
SQURPHARMA
৳222.60
7D
0.6%
1Y
-4.7%
IBN SINA Pharmaceutical Industry
Market Cap: ৳9.7b
Produces and sells pharmaceutical drugs in Bangladesh and internationally.
IBNSINA
৳311.20
7D
1.7%
1Y
-3.5%
SK Biopharmaceuticals
Market Cap: ₩7.7t
A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.
A326030
₩98,600.00
7D
-0.3%
1Y
-14.3%
PharmaEssentia
Market Cap: NT$165.5b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$496.50
7D
1.2%
1Y
-29.0%
China Medical System Holdings
Market Cap: HK$31.6b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$13.08
7D
-2.7%
1Y
83.7%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹471.5b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,783.45
7D
-0.6%
1Y
1.4%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥51.3b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.
688578
CN¥114.00
7D
25.6%
1Y
133.7%
Caplin Point Laboratories
Market Cap: ₹159.7b
Engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India.
524742
₹2,101.20
7D
-3.0%
1Y
10.1%
WuXi AppTec
Market Cap: CN¥299.4b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥103.30
7D
9.9%
1Y
163.7%
Zeria Pharmaceutical
Market Cap: JP¥89.2b
Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.
4559
JP¥2,023.00
7D
-2.4%
1Y
-12.5%